Wellbeing Digital Sciences, Inc. is a healthcare company, which engages in the development and implementation of innovative clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. The company is headquartered in London, Ontario. The company went IPO on 2021-01-27. The firm is focused on the development and implementation of clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. The company operates through three segments: Wellbeing & IRP; KGK Science and Mindscape. The company operates medical clinics across North America to help its patients access plant-based medicines, psychedelics, and other forms of mental health care, all of which have the potential to heal them of their physical and/or emotional pain. Its subsidiaries include Mindscape Ketamine & Infusions Therapy LLC, KGK Science Inc. and Integrated Rehab and Performance Ltd. The company is supported by a network of North American clinics that provide therapies and other types of treatment to patients, as well as through a contract research organization that offers clinical trials services to clients pursuing drug development.
Follow-Up Questions
What is Wellbeing Digital Sciences Inc (KONEF)'s P/E Ratio?
The P/E ratio of Wellbeing Digital Sciences Inc is 0
Who is the CEO of Wellbeing Digital Sciences Inc?
Ms. Najla Guthrie is the Chief Executive Officer of Wellbeing Digital Sciences Inc, joining the firm since 2021.
What is the price performance of KONEF stock?
The current price of KONEF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Wellbeing Digital Sciences Inc?
Wellbeing Digital Sciences Inc belongs to Health Care industry and the sector is Health Care
What is Wellbeing Digital Sciences Inc market cap?
Wellbeing Digital Sciences Inc's current market cap is $0
